Awarded contractOpenSuppliesGermany
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ixekizumab, ATC L04AC13 für die Zeit 01.07.2024 - 30.06.2026
1 supplier awarded•1 lot awarded•€1 awarded
Buyer: DAK-Gesundheit / Hamburg, Germany
Published Jul 02, 2026Awarded Jun 30, 2024
Pharmaceutical products
Awarded value
€1.0
Estimated value
€1.0
Awarded at 100% of estimated value
Award date
Jun 30, 2024
Winners
1
Lots awarded
1
Winners
Lots awarded
| Lot | Title | Winner | Award value | Main CPV |
|---|---|---|---|---|
| LOT-0001 | Lilly Deutschland GmbH | €1 | Pharmaceutical products (33600000) |